ישראל - עברית - Ministry of Health

rafa laboratories ltd - fentanyl - מדבקות - fentanyl 25 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fentanyl - מדבקות - fentanyl 75 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fentanyl - מדבקות - fentanyl 100 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - טבליות מצופות פילם - bosentan as monohydrate 125 mg - bosentan

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - טבליות מצופות פילם - bosentan as monohydrate 62.5 mg - bosentan

ישראל - עברית - Ministry of Health

unipharm ltd - valsartan 40 mg - film coated tablets - valsartan - valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalizations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

ישראל - עברית - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

ישראל - עברית - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ceftaroline fosamil - אבקה להכנת תמיסה מרוכזת לעירוי - ceftaroline fosamil 600 mg - ceftaroline fosamil - ceftaroline fosamil - zinforo is indicated in adults for the treatment of the following infections: • complicated skin and soft tissue infections (cssti)• community-acquired pneumonia (cap) consideration should be given to official guidance on the appropriate use of antibacterial agents.